+919405117673
Daratumumab 100mg/400mg Injection Global Supplier & Exporter – Cordium Pharmaceuticals Pvt Ltd
Daratumumab Injection 100mg/400mg is an advanced monoclonal antibody therapy widely used in the treatment of multiple myeloma and other hematological malignancies. Cordium Pharmaceuticals Pvt Ltd is a trusted Indian pharmaceutical exporter supplying genuine oncology medicines globally to hospitals, clinics, pharmacies, distributors, and personal import buyers with fast, reliable, and affordable shipping solutions.

What is Daratumumab Injection?

Daratumumab is a targeted anti-cancer medication that works by attacking CD38 proteins found on multiple myeloma cells. It helps the immune system identify and destroy cancer cells more effectively. Daratumumab is commonly prescribed as part of combination therapy or monotherapy in advanced oncology treatment protocols. According to medical references, Daratumumab is extensively used in modern hematology and oncology care for patients with relapsed or refractory multiple myeloma.

Available Strengths
Daratumumab 100mg Injection
Daratumumab 400mg Injection

These oncology injections are supplied in export-quality packaging with temperature-safe handling and secure international logistics support.

Uses of Daratumumab Injection

Daratumumab is primarily indicated for:

Multiple Myeloma Treatment
Relapsed or Refractory Multiple Myeloma
Combination Oncology Therapy
Advanced Hematology Treatments
Immunotherapy-Based Cancer Management

This targeted cancer therapy is widely used by oncologists, hematology specialists, and cancer treatment centers worldwide.

Benefits of Daratumumab 100mg/400mg
Advanced monoclonal antibody therapy
Targeted CD38 cancer cell destruction
Improved treatment response in multiple myeloma
Used in combination with chemotherapy and immunotherapy
Globally trusted oncology medication
Suitable for hospital and specialty clinic supply
Dosage & Administration

Daratumumab Injection should only be administered under qualified medical supervision in hospitals or oncology clinics.

Typical administration includes:

Intravenous infusion
Dosage based on patient body weight and treatment protocol
Administered in cycles as advised by oncologists
Requires patient monitoring during infusion

Patients must follow the prescribing physician’s instructions carefully.

Possible Side Effects

Like many oncology medicines, Daratumumab may cause certain side effects, including:

Common Side Effects
Fatigue
Nausea
Fever
Infusion-related reactions
Cough
Low blood cell counts
Serious Side Effects
Breathing difficulties
Severe allergic reactions
Infections
Liver complications

Medical supervision and regular monitoring are strongly recommended during treatment.

Why Choose Cordium Pharmaceuticals Pvt Ltd?

Cordium Pharmaceuticals Pvt Ltd is a growing pharmaceutical exporter from India specializing in oncology medicines, specialty pharmaceuticals, and global medicine supply services. The company supplies genuine medicines with competitive export pricing and international shipping support.

Key Advantages
Trusted Oncology Medicine Exporter
Global Pharmaceutical Supply Network
Fast & Reliable International Shipping
Affordable Export Pricing
Bulk Orders for Hospitals & Pharmacies
Personal Import Support
Secure Packaging & Documentation
Export Compliance Assistance
Global Export Countries

Cordium Pharmaceuticals Pvt Ltd supplies Daratumumab Injection globally, including:

United States
Germany
United Kingdom
Netherlands
South Africa
United Arab Emirates
Brazil

The company supports hospitals, oncology clinics, pharmacies, wholesalers, distributors, and personal import buyers with smooth export procedures and timely delivery.


Order & Enquiry

For bulk orders, hospital supply, distributor partnerships, pharmacy procurement, or personal import enquiries:

WhatsApp: +91-9505117673

Email: info@cordiumpharma.com

Website: www.cordiumpharma.com

Cordium Pharmaceuticals Pvt Ltd remains committed to delivering high-quality oncology medicines with dependable global export solutions for healthcare providers and patients worldwide.
May 23rd, 2026 12:20 PM

Keywords